Stock 4536 SANTEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Santen Pharmaceutical Co., Ltd.

Equities

4536

JP3336000009

Delayed Japan Exchange
Other stock markets
 09:32:00 27/06/2024 am IST 		5-day change 1st Jan Change
1,622 JPY -2.23% Intraday chart for Santen Pharmaceutical Co., Ltd. +1.06% +15.41%
10/05 Santen Pharmaceutical Intends to Buy Back and Cancel up to 38 Billion Yen Worth of Shares MT
09/05 Santen Pharmaceutical Co., Ltd. announces an Equity Buyback for 21,110,000 shares, representing 5.81% for ¥38,000 million. CI

Chart calendar Santen Pharmaceutical Co., Ltd.

09a.AiT8lGsV5eQQEdEn3ryFU-quKhUs33aYI1rJnwZZE0s.ckatxS5RqbFnJ6trmta9GabnXlgV5wOvWhOf2lM0QjNbdK7gAle63V12gA~94e083bcc624f051963bd4326fb4721e

Upcoming events on Santen Pharmaceutical Co., Ltd.

06/08/2024 Q1 2024 Earnings Release
07/11/2024 Q2 2024 Earnings Call
07/11/2024 Q2 2024 Earnings Release
06/02/2025 Q3 2024 Earnings Release
13/05/2025 Q4 2024 Earnings Call
13/05/2025 Q4 2024 Earnings Release
24/06/2025 Annual General Meeting
31/07/2025 Q1 2025 Earnings Release (Projected)
11/11/2025 Q2 2025 Earnings Release (Projected)
10/02/2026 Q3 2025 Earnings Release (Projected)
07/05/2026 Q4 2025 Earnings Release (Projected)

Past events on Santen Pharmaceutical Co., Ltd.

25/06/2024 Annual General Meeting
10/05/2024 Q4 2023 Earnings Call
09/05/2024 Q4 2023 Earnings Release
28/03/2024 Final dividend
08/02/2024 Q3 2023 Earnings Release
08/11/2023 Q2 2023 Earnings Call
07/11/2023 Q2 2023 Earnings Release
28/09/2023 Détachement de for dividende intermédiaire
03/08/2023 Q1 2023 Earnings Call
03/08/2023 Q1 2023 Earnings Release
27/06/2023 Annual General Meeting
11/05/2023 Q4 2022 Earnings Call
11/05/2023 Q4 2022 Earnings Release
13/04/2023 Analyst Meeting - Medium Term Management Plan 2023-2025
30/03/2023 Détachement de for final dividend
07/02/2023 Q3 2022 Earnings Call
07/02/2023 Q3 2022 Earnings Release
09/11/2022 Interim 2022 Earnings Call
08/11/2022 Interim 2022 Earnings Release
29/09/2022 Détachement de for dividende intermédiaire

Past dividends on Santen Pharmaceutical Co., Ltd.

28/03/2024 Final Payment 17 JPY
28/09/2023 Interim Payment 16 JPY
30/03/2023 Final Payment 16 JPY
29/09/2022 Interim Payment 16 JPY
30/03/2022 Final Payment 16 JPY
29/09/2021 Interim Payment 16 JPY
30/03/2021 Final Payment 14 JPY
29/09/2020 Interim Payment 14 JPY
30/03/2020 Final Payment 14 JPY
27/09/2019 Interim Payment 13 JPY

Annual results

Fiscal PeriodMarch 2019 2020 2021 2022 2023 2024
Net sales
Million JPY		Released
Forecast
Spread 		234 026
235 088
-0.45%		241 555
245 590
-1.64%		249 605
247 367
0.9%		266 257
263 731
0.96%		279 037
273 444
2.05%		301 965
301 449
0.17%
EBITDA
Million JPY		Released
Forecast
Spread 		56 067
55 242
1.49%		50 108
50 493
-0.76%		29 685
44 027
-32.57%		52 941
56 368
-6.08%		14 159
32 053
-55.83%		56 719
63 976
-11.34%
EBIT
Million JPY		Released
Forecast
Spread 		45 098
43 952
2.61%		33 535
37 882
-11.47%		12 917
22 943
-43.7%		35 886
39 523
-9.2%		-3 090
-4 983
37.99%		38 541
44 636
-13.65%
Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		43 117
42 989
0.3%		32 091
34 188
-6.13%		12 418
22 200
-44.06%		35 616
39 086
-8.88%		-5 799
-7 540
23.09%		29 874
41 245
-27.57%
Net income
Million JPY		Released
Forecast
Spread 		31 954
31 939
0.05%		23 618
25 173
-6.18%		6 830
14 029
-51.31%		27 218
29 030
-6.24%		-14 948
-15 825
5.54%		26 642
31 721
-16.01%
EPS
JPY		Released
Forecast
Spread 		78,7
79,1
-0.55%		59,2
66,0
-10.42%		17,1
34,9
-51%		68,1
72,7
-6.33%		-38,6
-42,4
8.96%		72,6
90,9
-20.13%
Announcement Date09/05/1908/05/2011/05/2110/05/2211/05/2309/05/24

Quarterly results

Fiscal PeriodMarch 2020 S1 2021 S1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4 2026 S1
Net sales
Million JPY		Released
Forecast
Spread 		118 775
116 000
2.39%		118 905
116 600
1.98%		128 759
118 850
8.34%		67 042
66 461
0.87%		70 456
68 699
2.56%		65 533
61 050
7.34%		63 382
63 188
0.31%		128 915
131 800
-2.19%		70 871
69 762
1.59%		79 251
76 787
3.21%		72 389
67 033
7.99%		73 417
66 056
11.14%		145 806
140 000
4.15%		77 027
73 700
4.51%		79 132
78 097
1.33%
69 922


70 583


146 000


75 600


80 634


140 500

EBITDA
Million JPY		Released
Forecast
Spread






































15 743
13 700
14.91%



15 116


13 003





16 021


19 059




EBIT
Million JPY		Released
Forecast
Spread 		19 000
13 100
45.04%		18 686
17 100
9.27%		18 805
21 500
-12.53%		7 575
10 260
-26.17%		9 506
13 120
-27.55%		8 333
6 750
23.45%		-27 354
6 784
-503.24%		-19 021
17 900
-206.26%		8 874
7 599
16.78%		7 057
5 993
17.76%		12 750
7 400
72.3%		12 349
4 775
158.62%		25 099
16 600
51.2%		11 058
9 000
22.87%		2 384
6 973
-65.81%
10 550


8 800


25 800


12 500


12 300


25 400

Earnings before Tax (EBT)
Million JPY		Released
Forecast
Spread 		18 400
13 000
41.54%		18 353
17 000
7.96%		18 393
19 000
-3.19%		7 280
11 796
-38.28%


9 074
5 900
53.8%		-28 177
8 565
-428.98%		-19 103
17 900
-206.72%		7 510
8 686
-13.53%		5 794
3 967
46.05%		12 868
7 950
61.86%


24 075
15 300
57.35%		9 484
7 500
26.45%



11 458


8 703


24 700


11 821


15 529


24 300

Net income
Million JPY		Released
Forecast
Spread 		13 100
13 000
0.77%		13 813
12 200
13.22%		14 307
14 145
1.15%		5 042
8 396
-39.95%


6 663
4 400
51.43%		-28 704
6 065
-573.27%		-22 041
13 400
-264.49%		5 977
6 281
-4.83%		1 116
967
15.41%		10 414
5 975
74.29%		8 866
2 900
205.72%		19 280
12 200
58.03%		7 333
5 700
28.65%		29,0
6 347
-99.54%
8 654


6 369


19 100


8 739


11 654


18 700

EPS
JPY		Released
Forecast
Spread 		32,9
32,6
1.04%		34,6
29,7
16.43%		35,8
35,4
1.1%		12,6
14,8
-14.58%		19,7
19,6
0.36%		16,8
12,0
39.68%		-72,8
9,66
-854.04%		-56,1
34,6
-261.99%		14,9
11,9
25.22%		2,53
2,33
8.58%		27,9
17,6
59.05%		24,1
13,2
82.94%		52,1
30,5
70.69%		20,2
16,8
20.53%		0,33
12,5
-97.35%
22,3


18,9


47,8


27,1


26,5


46,8

Announcement Date06/11/1906/11/2008/11/2110/02/2210/05/2204/08/2208/11/2208/11/2207/02/2311/05/2303/08/2307/11/2307/11/2308/02/2409/05/24------

Upcoming sector events for Santen Pharmaceutical Co., Ltd.

04/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
11/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
16/07/2024 CAMURUS AB: Q2 2024 Earnings Release
17/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 04:15 pm JOHNSON & JOHNSON: Q2 2024 Earnings Release
18/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 10:30 am NOVARTIS AG: Q2 2024 Earnings Release
22/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
22/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
23/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Santen Pharmaceutical Co., Ltd.

21/06/2024 08:58 pm DEVA HOLDING: Q1 2024 Earnings Release
14/06/2024 02:51 am EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 11:00 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 04:03 pm SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 02:47 pm LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 05:38 pm SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 04:30 pm ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 11:54 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 05:30 pm FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 02:56 pm JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4536 Stock
  4. Calendar Santen Pharmaceutical Co., Ltd.